Trial Information

Summary: Got Zits

We are conducting a research study evaluating an investigational therapy for moderate to severe acne.

We are looking for participants who are:

  • 12 years or older with moderate to severe acne
  • In good general health

Patient Exclusion Criteria:

  • Subject is pregnant, lactating, or is planning to become pregnant during the study.
  • Subject has greater than 4 facial nodules.

Qualified participants will receive compensation for visits. Skin examinations by Kenneth Beer, M.D., & Jill Waibel, M.D., Board Certified Dermatologist. All visits and study treatment at no cost., Reimbursement for time and travel. No health insurance required. Must have moderate to severe acne to qualify, but for more information please call to schedule an appointment to see if you qualify.

Contact:

Monica Dunn, BSN, RN, Clinical Coordinator
Florida Dermatology Institute
1500 N.Dixie Highway Suite 305
West Palm Beach, FL 33401
Telephone: 561-655-9055
Fax: 561-655-9233
Email:

Profile Page: Florida Dermatology Institute, West Palm Beach, FL

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:33:26 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA